🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2005-12
Trial ID
NCT00648219
Treatments Being Tested
In patients naive to treatment or after a 2-week washout period for patient...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00890591
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of Olostar Table...
Status
Active Not Recruiting
Location
Severance Hospital
Start Date
2022-06-20
Trial ID
NCT05411887
Treatments Being Tested
The investigators want to find out whether a recently introduced combinatio...
Status
Completed
Location
Praxis Dr. Loddo
Start Date
2011-12
Trial ID
NCT01613209
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of azilsa...
Status
Completed
Location
Multiple Locations
Start Date
2004-08
Trial ID
NCT00759551
Treatments Being Tested
The treatment period was 16 weeks, the initial dose, 5 mg, was unforcedly t...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00914524
Treatments Being Tested
To assess the efficacy of individually optimized doses of olmesartan medoxo...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00751751
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
PRACS Institute Ltd.
Start Date
2006-11
Trial ID
NCT01019590
The purpose of the study is to test the efficacy and safety of the combinat...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00858702
Treatments Being Tested
This study will evaluate the efficacy and safety of valsartan and amlodipin...
Status
Completed
Location
Novartis Investigative Site, , Germany
Start Date
2007-07
Trial ID
NCT00523744
Treatments Being Tested